Richard Vincent to take over in February 2017.
Australian Pharmaceutical Industries has just announced the resignation of its ceo and managing director Stephen Roche, who will step down in February next year.
The company said it’s implementing a transition plan which will see API’s general manager of Business Development, Operations and Strategy, Richard Vincent, take over.
Vincent has been with API since 2005 and is currently responsible for API’s pharmacy operations, IT and the consumer manufacturing business in New Zealand.
API chairman Peter Robinson paid tribute to Roche, who he said had delivered on a range of initiatives including strong growth in the Priceline Pharmacy network and the restructuring of the company’s wholesaling operations.
API also updated the guidance provided in July, confirming that underlying net profit after tax for the 2016 financial year would be at least $51 million.
More details in today’s issue of Pharmacy Daily.
